Predictive Oncology stockholders elect Nuzum and Handley, approve stock plan increase

The Company’s stockholders ratified the appointment of Baker Tilly Virchow Krause, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. There were 31,958,683 votes cast for the proposal; 4,713,124 votes cast against the proposal; 588,435 votes abstained, and there were no broker non-votes.

The Company’s stockholders elected two Class I members, Chuck Nuzum and Daniel E. Handley, M.S., Ph.D., to the Company’s Board of Directors. The stockholders present in person or by proxy cast the following numbers of votes in connection with the election of directors: Nominee Votes For Votes Withheld Chuck Nuzum 17,327,984 8,313,223 Daniel E. Handley, M.S., Ph.D. 15,886,840 9,754,367

The Company’s stockholders approved a proposal to amend the Company’s Amended and Restated 2012 Stock Incentive Plan to increase the reserve of shares of common stock authorized for issuance thereunder from 3,250,000 to 5,750,000 (the “Plan Increase Proposal”). There were 14,173,961 votes cast for the proposal; 11,069,344 votes cast against the proposal; 397,902 votes abstained, and there were 11,619,035 broker non-votes.

The Company’s stockholders did not approve a proposal to adjourn the Annual Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there were insufficient votes to approve the Plan Increase Proposal (Proposal 3) at the time of the Annual Meeting or if the Company did not have a quorum. There were 12,361,835 votes cast for the proposal; 14,035,330 votes cast against the proposal; 602,196 votes abstained, and there were 10,260,881 broker non-votes.

Pursuant to an advisory vote regarding the frequency of future “say-on-pay” votes, the Company’s stockholders approved conducting “say-on-pay” votes every year. There were 18,201,538 votes cast for conducting “say-on-pay” votes every year; 415,485 votes cast for conducting “say-on-pay” votes every two years; and 4,030,636 votes cast for conducting “say-on-pay” votes every three years. 2,993,547 votes abstained, and there were 11,619,036 broker non-votes.

Pursuant to an advisory “say-on-pay” vote, the Company’s stockholders approved the compensation of the Company’s executive officers as described in the Company’s proxy statement. There were 13,336,538 votes cast for the proposal; 11,882,246 votes cast against the proposal; 422,423 votes abstained, and there were 11,619,035 broker non-votes.